Diastolic heart failure - Therapy;Diastolische herzinsuffizienz - Therapie

Deutsche Medizinische Wochenschrift

Volumn 130, Issue 19, 2005, Pages 1213-1216

  Schmidt, A G ^a   Pieske, Burkert ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; CARVEDILOL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; FUROSEMIDE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; ISOSORBIDE DINITRATE; LISINOPRIL; LOSARTAN; METOPROLOL; NITRIC ACID DERIVATIVE; NITROPRUSSIDE SODIUM; RAMIPRIL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

DIASTOLE; DIASTOLIC HEART FAILURE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP APNEA SYNDROME; TREATMENT INDICATION; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; PROGNOSIS;

CORONARY DISEASE; DIABETES COMPLICATIONS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MYOCARDIAL ISCHEMIA; PROGNOSIS; SLEEP APNEA, OBSTRUCTIVE;

EID: 20044386547     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-868703     Document Type: Review

References (20)

1. Aurigemma GP, Gaasch WH. Diastolic heart failure. N Engl J Med 2004; 351: 1097-1105
2. Alchanatis M, Tourkohoriti G, Kosmas EN et al. Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 2002; 20: 1239-1245
3. Bergstrom A, Andersson B, Edner M, Nylander E, Persson H, Dahlstom U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function: Results of the Swedish Doppler-echocardiography study (SWEDIC). Eur J Heart Fail 2004; 6: 453-461
4. Böger RH. Wie wird die chronische Herzinsuffizienz heute tatsächlich behandelt. Dtsch Med Wochenschr 2002; H34: 1764
5. Böhm M. Werden Herzglykoside zur Therapie der Herzinsuffizienz noch benötigt? Dtsch Med Wochenschr 2002; 41: 2133
6. Chobanian AV, Bakris GL, Black HR et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206
7. Colucci WS. Nesiritide for the treatment of decompensated heart failure. J Card Fail 2001; 7: 92-100
8. Devereux RB, Dahlof B, Gerdts E et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004; 110: 1456-1462
9. Gandhi SK, Powers JC, Nomeier AM et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344: 17-22
10. Hunt SA, Baker DW, Chin MH et al. ACC/AHA Guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. Circulation 2001; 104: 2996-3007
11. Kindermann M, Janzen I, Hennen B, Böhm M. Chronische Herzinsuffizienz-Therapie. Dtsch Med Wochenschr 2002; H21: 1139
12. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-1560
13. Setaro JF, Zaret BL, Schulman DS et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 1990; 66: 981-986
14. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Eng J Med 1997; 336: 525-533
15. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosteron-system. Circulation 1991; 83: 1849-1865
16. Yusuf S, Pfeffer MA, Swedberg K et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777-781
17. Zannad F, Allo F, Dousset B et al. Limitation of the extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 2000; 102: 2700-2706
18. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part II. Causal Mechanisms and Treatment. Circulation 2002; 105: 1503-1508
19. Hader C, Sanner B, Rasche K. Das obstruktive Schlafapnoe-Syndrom - Diagnostik. Dtsch Med Wochenschr 2004; 11: 566-569
20. Sanner B, Hader C, Rasche K. Das obstruktive Schlafapnoe-Syndrom - Therapie. Dtsch Med Wochenschr 2004; 11: 570-572